ReviewMolecular biology reports2025
The role of the casein kinase 1 (CK1) family in fungal infections.
Review in Molecular biology reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
The Casein kinase 1 (CK1) family, as an important member of the protein kinase family, exhibits high evolutionary conservation and is widely distributed in various cell types. CK1 plays critical roles in numerous cellular biological processes, and its abnormal expression is closely associated with the development and progression of various diseases. The CK1 protein family has been extensively studied and reported as an influential factor in various mammalian diseases. Increasing evidence indicates that the CK1 family also plays an indispensable role in fungal growth and infection processes. For example, CK1 protein in Candida albicans plays a crucial role in virulence and drug resistance; CK1 protein in Cryptococcus neoformans affects cell integrity and stress response; and CK1 protein in Magnaporthe oryzae and Fusarium graminearum is involved in fungal growth, conidiation, and pathogenesis. Advances in protein kinase inhibitor research, particularly through enhanced understanding of kinase-substrate interactions and species-specific structural features, are poised to enable the development of highly specific fungal CK1 inhibitors with improved anti-fungi indices.
Indexed as
Identifiers
40285862What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.